
Oncology NEWS International
- Oncology NEWS International Vol 16 No 3
- Volume 16
- Issue 3
People and Places
Dr. Richard Schilsky, Dr. Edward Pan, Pam Kedziera
Dr. Richard Schilsky
Richard L. Schilsky, MD, associate dean for clinical research at the University of Chicago Pritzker School of Medicine, has been elected president of the American Society of Clinical Oncology for the 2008-2009 term. He will be inducted as president-elect at ASCO's 43rd Annual Meeting in June 2007. Dr. Schilsky's interests include GI cancers, cancer pharmacology, and drug development.
Dr. Edward Pan
The Orlando campus of M.D. Anderson has added neuro-oncologist Edward Pan, MD, to its staff. Dr. Pan comes to M.D. Anderson from the Florida Hospital Cancer Institute where he was co-medical director of neuro-oncology. Prior to that appointment, he was on faculty as a clinical instructor for the Brain Tumor Research Center at the University of California, San Francisco.
Pam Kedziera
Fox Chase Cancer Center has named Pam Kedziera, RN, MSN, ACON, as clinical director of the center's pain and palliative care program. In her new role, she will help lead expansion of the pain management center into a broader focused program while continuing to direct the staff and programs offered at the center. Ms. Kedziera has been affiliated with Fox Chase since 1980.
Articles in this issue
almost 19 years ago
Peptide-Based Breast Ca Vaccines Promising in Early Trialsalmost 19 years ago
Diagnostic Dilemma: GI Diseasealmost 19 years ago
Imatinib Responses in CML May Take Timealmost 19 years ago
IV Vidaza Approved; Oral Formulation to Be Testedalmost 19 years ago
Study Confirms Avastin Advantage in Advanced NSCLCalmost 19 years ago
Legal Services Should Be a Component of Standard Cancer Carealmost 19 years ago
Mouse Virus Evidence Suggests Viral Basis for Breast Caalmost 19 years ago
Groups Oppose Ruling on Access to Experimental Drugsalmost 19 years ago
Satellite Allows Digital Mammography Screening for Rural Native Americansalmost 19 years ago
Nexavar Effective in Advanced HCC: Phase III Trial StoppedNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
































































































